Nosocomial outbreak by Proteus mirabilis producing extended-spectrum β-lactamase VEB-1 in a Korean university hospital
Author(s) -
Jayoung Kim,
Yeon-Joon Park,
Sang-Il Kim,
Moon Won Kang,
Seungok Lee,
Kyo-Young Lee
Publication year - 2004
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkh486
Subject(s) - cefotaxime , ceftazidime , proteus mirabilis , microbiology and biotechnology , imipenem , aztreonam , cefoxitin , piperacillin , cefepime , cefuroxime , cephalosporin , cefpodoxime , tazobactam , biology , antibiotics , antibiotic resistance , pseudomonas aeruginosa , bacteria , genetics , staphylococcus aureus
To examine the molecular mechanisms involved in the beta-lactam resistance of multidrug-resistant Proteus mirabilis isolates that showed an unusual synergy between imipenem and ceftazidime in a Korean hospital.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom